Company intelligence / Profile preview

KCell Biosciences

Busan, Busan, South Koreak-cell.com ↗

Ownership: Private
Development stage: Commercial

Overview

KCell Biosciences has established Korea’s largest mass-production capacity for serum-free and chemically defined cell culture media. The company supplies customized solutions for biopharmaceuticals, vaccines, stem cells, immune cells, recombinant proteins, and the cellular agriculture sector. It offers both powder and liquid formats as well as contract development services for cell lines/media. No clinical trial results are reported since it does not develop therapeutics directly.

Modalities: Recombinant protein (as a product)Cell culture media (enabling technology for biologics/cell therapy/vaccines)Stem cell therapy (enabling materials/services)Vaccine (enabling materials/services)
Industry: Chemicals & Materials

Partnerships

Joint venture between WSG (Korea) and Thousand Oaks Biopharmaceuticals (USA)

Beyond the preview

Go deeper on KCell Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KCell Biosciences.

Explore the full profile